Ajax-Loading

Johnson & Johnson - Ebitda Per Share

Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD.

The item "Ebitda-Per-Share" stands at 16.58 United States Dollars as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.

As of the end of Johnson & Johnson's third quarter, the item "Ebitda Per Share" stands at 16.58 USD. This represents an increase of 13.04 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 56.61 percent compared to the value the year prior.
The 1 year change in percent is 56.61.
The 3 year change in percent is 35.65.

The Serie's long term average value is 11.64 United States Dollars. It's latest available value, on 09/30/2025, is 42.44 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is +78.30%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Ebitda Per Share for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Ebitda Per Share905,699,262,464.00
LogoAbbVie Inc - Ebitda Per Share399,570,305,024.00
LogoRoche Holding AG - Ebitda Per Share317,433,206,677.55
LogoAstraZeneca PLC - Ebitda Per Share280,205,508,085.11
LogoNovartis AG - Ebitda Per Share255,096,620,580.91